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Abstract: Sera from 1133 Turkish horses were obtained and tested for equid herpesvirus 3 (EHV-3) antibodies using a sero-neutralisation
test. The sample consisted of 420 privately owned working horses from 2 regions of Turkey, 428 brood horses from private stud farms
and breeding stations, and 285 racehorses from private stud farms. Neutralising antibodies against EHV-3 were found in 287 (25.3%)
of the 1133 analysed sera. The highest seroprevalence for EHV-3 was detected in the brood horses (51.2%), followed by the racehorses
(10.2%), and the working horses (9.3%). The seroprevalence rates tended to be higher in female horses than in male horses for all 3
horse populations tested (P < 0.01). The findings indicate significant differences in EHV-3 seropositivity rates between horses used for
breeding and those used for work and racing (P < 0.001), suggesting that the intended use of horses may be an important factor in the
epidemiological assessment of EHV-3 infection.
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1. Introduction
Equid herpesvirus 3 (EHV-3) causes an acute
venereal disease called equine coital exanthema in
mares and stallions. EHV-3 is a member of subfamily
Alphaherpesvirinae within the family Herpesviridae (1–3).
The infection is recognised by the formation of papules,
vesicles, pustules, and ulcers on the genital region of
mares and stallions (4,5). EHV-3 is transmitted through
coitus via semen and through noncoital examinations via
virus-contaminated equipment. Subsequent to primary
infection, as in other alphaherpesviruses, the virus can
result in a life-long latent infection (2,4). Horses with
subclinical and latent infection play an important role in
the transmission of the disease (2) as virus reactivation
occurs in seropositive animals (5).
The infection was first clinically recognised in
Ireland (6,7). Several studies indicated that the infection
is widespread in embryo transfer and in horse breeding
centres around the world where the prevalence varies
from 6%–58% (2,8–10), although there have been limited
reports on the prevalence of EHV-3 in working horses
(1,11). The purpose of this study was to investigate the
seroprevalence of EHV-3 in various horse populations in
* Correspondence: soydalata@hotmail.com

Turkey, for which there was no information available, in
an effort to assess the regional baseline infection/disease
prevalence rate and to guide future epidemiological
studies.
2. Materials and methods
2.1. Study area and sampled animals
The animal panel consisted of 1133 sera obtained
from Turkish horses: 420 privately owned indigenousbred horses used as pack animals in the Aegean and
Mediterranean regions (2012 and 2013), 428 brood horses
(Thoroughbred and Haflinger breeds), and 285 racehorses
(Thoroughbred and Arabian breeds) from private stud
farms and breeding stations affiliated with the Jockey
Club of Turkey (2013). The Jockey Club of Turkey is the
primary official foundation for breeding of both brood
horses and racehorses in Turkey. In the 4 sampling areas
for brood horses and racehorses, horse stud farms were
common. The fifth area had only one Haflinger stud farm
(Table). These brood horses are mated once a year. In the
event of pregnancy they are kept under the supervision
of a veterinarian at a private stud farm or horse stable
affiliated with the Jockey Club of Turkey. All the sera were
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taken randomly from apparently healthy horses that were
likely older than 1 year. The sexes of all the horses were
recorded. The Laboratory Animal Ethics Committee of
Mustafa Kemal University (Hatay, Turkey) approved the
study protocol.
2.2. Sero-neutralisation test (SNT)
The reference EHV-3 strain, at a titre of 104.5 50% tissue
culture infective doses (TCID50)/mL, propagated in equine
dermis cell culture was used for the sero-neutralisation
test. Serial 2-fold dilutions (from 1:4 to 1:512) of the horse
sera prepared with Dulbecco’s minimum essential medium
in 96-well cell culture microplates were assayed for EHV3-specific virus-neutralising antibodies as described
elsewhere (12). Antibody titres of 1:4 and higher were
recorded as positive.
2.3. Statistical analysis
The seroprevalence results for EHV-3 were expressed
in percentages. The subjects were divided into 3 groups
according to their intended use: brood horses, racehorses,
and working horses. The 3 groups were further divided into
2 subgroups according to sex. The brood horses were also
grouped according to the stud from which they originated.
A chi-square test was used to determine the association

between the seroprevalence results of the groups and the
subgroups. The overall data analysis was performed using
SPSS (ver. 15.0) (SPSS Inc., Chicago, IL, USA).
3. Results
Based on the results of the sero-neutralisation test, the
overall seropositivity rate against EHV-3 in the 1133
Turkish horses sampled was 25.3% (Table). Among the
420 privately owned horses in the 2 regions of Turkey,
EHV-3 antibodies were found in 39 (9.3%) of the analysed
sera samples. Two hundred and nineteen (51.2%) of the
428 brood horse serum samples from the stud farms were
positive for EHV-3 antibodies, and specific antibodies
against EHV-3 were found in 29 (10.2%) of the 285 sera
samples of the racehorses. With regard to the intended
use of the horses, the differences in EHV-3 seroprevalence
were statistically more significant (P < 0.001) in the brood
horses compared with the racehorses and the working
horses.
The EHV-3 seroprevalence was comparable in female
(36.8%) and male (12.3%) horses. Among the 420 privately
owned horses from the 2 regions in Turkey, 15 (5.4%) of
276 male horse sera and 24 (16.7%) of 144 female horse

Table. Distribution and seropositivity rates of sera sampled from Turkish horses.

Sampling
area no.

Brood horse
(n: 428)
Seropositive
% (n)

Racehorse
(n: 285)
Sex
% (n)

Seropositive
% (n)

♂
(n: 93)

♀
(n: 335)

Working horse
(n: 420)
Sex
% (n)

Seropositive
% (n)

♂
(n: 161)

♀
(n: 124)

Sex
% (n)
♂
(n: 276)

♀
(n: 144)

1

47.1a
(49/104)

100.0
(3/3)

45.5
(46/101)

10.3(28/271)

8.7
(13/149)

12.3
(15/122)

12.3(22/178)

9.2
(11/120)

18.9
(11/58)

2

68.7 b
(11/16)

-

68.7
(11/16)

7.1(1/14)

8.3
(1/12)

0.0
(0/2)

7.0(17/242)

2.6
(4/156)

15.1
(13/86)

3

77.9 b
(67/86)

-

77.9
(67/86)

-

-

-

-

-

-

4

41.7 a
(78/187)

35.6
(26/73)

45.6
(52/114)

-

-

-

-

-

-

5*

37.1 a
(13/35)

41.1
(7/17)

33.3
(6/18)

-

-

-

-

-

-

Total % (n)

51.2A
(219/428)

38.7
(36/93)

54.6
(183/335)

10.2 B
(29/285)

8.7
(14/161)

12.1
(15/124)

9.3 B
(39/420)

5.4
(15/276)

16.7
(24/144)

*Haflinger farm
ab: significant differences in the same column.
AB: significant differences in the same row.
-: Statistically no differences in the same column.
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sera tested were positive for EHV-3 antibodies. Of the 428
brood horse serum samples tested from the stud farms, 36
(38.7%) of 93 stallion sera and 183 (54.6%) of brood mare
sera tested were positive for EHV-3 antibodies. Of the 285
racehorses sampled, 14 (8.7%) samples from male horses
and 15 (12.1%) from female horses tested were positive for
EHV-3 antibodies (Table).
Statistically significant differences in the EHV-3
seroprevalence were observed between sexes in brood
and working horses (P < 0.01), whereas there was no
statistically significant difference observed in the EHV-3
seroprevalence in racehorses (P < 0.05). The seropositivity
rate was higher in the stud farms in the second and third
sampling areas compared with the stud farms in the first,
fourth, and fifth sampling areas; and this finding was
statistically significant (P < 0.001).
4. Discussion
Although EHV-3 infection is usually characterised as
localised, it causes significant problems for horse breeding
by restraining the application of embryo transfer and
artificial insemination, as well as temporarily affecting the
mating activities of brood horses due the highly contagious
nature of the infection (4,10,13). The presence of infection
has been reported in Australia, Argentina, Austria,
Canada, Denmark, Norway, the US, the UK, Japan, India,
and Mongolia (1,2,4,7,8,11,14–16). The seroprevalence
of EHV-3 is about 18%–53% around the world (4,7,8).
Antibodies specific to EHV-3 were detected in about
27%–48% of horses, without any clinical signs (2,4). In
this study the overall seropositivity rate against EHV-3 in
the Turkish horses sampled was 25.3%. The seroprevalence
rates were higher in brood horses (both mares and
stallions) compared with the racehorses and the working
horses. Furthermore, the seropositivity rates for EHV-3
infection among the brood and working horse populations
tested in this study tended to be higher in female horses
than in male horses (P < 0.01). These results suggest that
EHV-3 prevalence could be affected by the intended use of

the horse populations. The higher seroprevalence rate of
EHV-3 infection in the breeder horses might be due to the
high rate of mating and inspection of the genital organs of
these animals. This may increase the likelihood of venereal
transmission of the virus, as observed by Pagamjav et
al. (11) and Barrandeguy et al. (2,10). However, it is still
unknown whether the original source of the infection in
working horses is other horses or the environment.
The number of EHV-3 antibody-positive brood horses
was much higher in the brood studs in the second and
third sampling areas, and the difference was statistically
significant (P < 0.001). The progression of equine
herpesviruses is associated with various factors such as
climate conditions, population status, development of
management practices, quarantine in infected areas, and
other infections (17,18). Disruptions in quarantine and
poor management practices at the horse breeding stations
and brood stud farms sampled may explain the high rate of
seroprevalence in this study.
In conclusion, this serosurvey indicates low circulation
of EHV-3 in racehorses and working horses but high
circulation in brood horses at stud farms in Turkey.
It suggests that the intended use of horses may be an
important factor in epidemiological assessments of EHV3 infection. As there is no vaccine available for EHV-3, and
many infections spread rapidly as a result of globalisation,
prevention and control strategies for EHV-3 infection
should focus on epidemiological screening, development
of management practices at stud farms, and strict hygiene
practices at breeding stations.
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